Unicycive Therapeutics/$UNCY
1D1W1MYTD1Y5YMAX
Capital at risk
About Unicycive Therapeutics
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
- Ticker
- $UNCY
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 22
- Headquarters
- Mountain View, United States
- Website
- unicycive.com
UNCY Metrics
BasicAdvanced
$138M
-
-$1.56
1.78
-
Price and volume
Market cap
$138M
Beta
1.78
52-week high
$8.74
52-week low
$3.71
Average daily volume
801K
Financial strength
Current ratio
3.813
Quick ratio
3.284
Long term debt to equity
0.001
Total debt to equity
0.013
Interest coverage (TTM)
-571.17%
Profitability
EBITDA (TTM)
-33.094
Management effectiveness
Return on assets (TTM)
-40.59%
Return on equity (TTM)
-101.07%
Valuation
Price to book
2.59
Price to tangible book (TTM)
2.59
Price to free cash flow (TTM)
-4.025
Free cash flow yield (TTM)
-24.84%
Free cash flow per share (TTM)
-1.232
Growth
Earnings per share change (TTM)
-46.19%
3-year earnings per share growth (CAGR)
-57.18%
Upcoming events
No upcoming events
UNCY News
AllArticlesVideos
Kaplan Fox Announces a Securities Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) - Lead Plaintiff Deadline is November 2, 2026
Newsfile Corp9 hours ago
ROSEN, A TOP RANKED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - UNCY
Newsfile Corp22 hours ago
UNCY EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Unicycive Therapeutics (UNCY) Investors of Securities Class Action Lawsuit Deadline on November 2, 2026
Newsfile Corp23 hours ago
Funds containing UNCY
Fund name | Fund size | $UNCY weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.